The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“early studies of individual Commander subunits (COMMD1 and COMMD7) implicated these proteins in regulating NF-κB levels and transcriptional pathways through interactions with cullin-containing ubiquitin ligases.12,34,35,36,37,38,39,40”
From Structure of the endosomal Commander complex linked to Ritscher-Schinzel syndrome (2023) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shan, J., Shen, J., Liu, L., Xia, F., Xu, C., Duan, G., Xu, Y., Ma, Q., Yang, Z., Zhang, Q., et al. (2012) · Hepatology · doi:10.1002/hep.25745 · Cited by 296
Research works printed but not linked: 39
- Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 · DOI · Paper page
- Mittal, 2013, Epidemiology of hepatocellular carcinoma: consider the population, J. Clin. Gastroenterol., 47, S2, 10.1097/MCG.0b013e3182872f29 · DOI · Paper page
- Mir, 2017, Epithelial-to-mesenchymal transition: a mediator of sorafenib resistance in advanced hepatocellular carcinoma, Curr. Cancer Drug Targets, 17, 698, 10.2174/1568009617666170427104356 · DOI
- Llovet, 2014, Liver cancer: time to evolve trial design after everolimus failure, Nat. Rev. Clin. Oncol., 11, 506, 10.1038/nrclinonc.2014.136 · DOI
- Jiang, 2017, miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma, J. Exp. Clin. Cancer Res, 36, 99, 10.1186/s13046-017-0568-3 · DOI
- El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 · DOI · Paper page
- Visvader, 2008, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nat. Rev. Cancer, 8, 755, 10.1038/nrc2499 · DOI · Paper page
- Clarke, 2006, Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells, Cancer Res., 66, 9339, 10.1158/0008-5472.CAN-06-3126 · DOI · Paper page
- Dean, 2005, Tumour stem cells and drug resistance, Nat. Rev. Cancer, 5, 275, 10.1038/nrc1590 · DOI · Paper page
- Yang, 2008, Significance of CD90+ cancer stem cells in human liver cancer, Cancer Cell, 13, 153, 10.1016/j.ccr.2008.01.013 · DOI · Paper page
- Xu, 2017, Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling, Oncotarget, 8, 16972, 10.18632/oncotarget.15216 · DOI
- Song, 2013, Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review), Oncol. Rep., 29, 3, 10.3892/or.2012.2082 · DOI
- Huo, 2017, Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells, Mol. Cancer, 16, 165, 10.1186/s12943-017-0734-4 · DOI · Paper page
- Hayden, 2012, NF-κB, the first quarter-century: remarkable progress and outstanding questions, Genes Dev., 26, 203, 10.1101/gad.183434.111 · DOI · Paper page
- Hassanzadeh, 2011, Colorectal cancer and NF-κB signaling pathway, Gastroenterol. Hepatol. Bed Bench, 4, 127
- Wang, 2014, Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: involvement of NF-κB signaling pathway, Biochem. Pharmacol., 88, 322, 10.1016/j.bcp.2014.01.041 · DOI
- Lin, 2010, The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy, Expert Opin. Ther. Targets, 14, 45, 10.1517/14728220903431069 · DOI · Paper page
- Bartuzi, 2013, Tuning NF-κB activity: a touch of COMMD proteins, Biochim. Biophys. Acta, 1832, 2315, 10.1016/j.bbadis.2013.09.014 · DOI · Paper page
- Burstein, 2005, COMMD proteins, a novel family of structural and functional homologs of MURR1, J. Biol. Chem., 280, 22222, 10.1074/jbc.M501928200 · DOI · Paper page
- Geng, 2009, Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination, EMBO Rep., 10, 381, 10.1038/embor.2009.10 · DOI
- Zoubeidi, 2010, Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells, Mol. Cancer Res., 8, 119, 10.1158/1541-7786.MCR-09-0277 · DOI
- Fernández Massó, 2013, The antitumor peptide CIGB-552 increases COMMD1 and inhibits growth of human lung cancer cells, J. Amino Acids, 2013, 251398
- You, 2017, COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma, Mol. Carcinog., 56, 607, 10.1002/mc.22520 · DOI
- Zheng, 2012, ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth, PLoS ONE, 7, e45412, 10.1371/journal.pone.0045412 · DOI
- Zheng, 2016, COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma, Oncotarget, 7, 32774, 10.18632/oncotarget.9047 · DOI
- Esposito, 2016, COMMD7 as a novel NEMO interacting protein involved in the termination of NF-κB signaling, J. Cell. Physiol., 231, 152, 10.1002/jcp.25066 · DOI · Paper page
- Mabb, 2006, PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress, Nat. Cell Biol., 8, 986, 10.1038/ncb1458 · DOI · Paper page
- You, 2017, COMMD7 promotes hepatocellular carcinoma through regulating CXCL10, Biomed. Pharmacother., 88, 653, 10.1016/j.biopha.2017.01.046 · doi:10.1016/j.biopha.2017.01.046
- Meng, 2010, Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer, Cancer Biol. Ther., 9, 295, 10.4161/cbt.9.4.10666 · DOI · Paper page
- Jeter, 2009, Functional evidence that the self-renewal gene NANOG regulates human tumor development, Stem Cells, 27, 993, 10.1002/stem.29 · DOI · Paper page
- Tang, 2008, Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling, Proc. Natl. Acad. Sci. USA, 105, 2445, 10.1073/pnas.0705395105 · DOI · Paper page
- Oliva, 2010, The identification of stem cells in human liver diseases and hepatocellular carcinoma, Exp. Mol. Pathol., 88, 331, 10.1016/j.yexmp.2010.01.003 · DOI
- Tanaka, 2006, Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer, J. Pathol., 208, 662, 10.1002/path.1928 · DOI · Paper page
- Mizuguchi, 1998, Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes, J. Cell. Physiol., 174, 273, 10.1002/(SICI)1097-4652(199803)174:3<273::AID-JCP1>3.0.CO;2-L · DOI
- Saha, 2014, Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer, Nature, 513, 110, 10.1038/nature13441 · DOI · Paper page
- Walesky, 2015, Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer, Gene Expr., 16, 101, 10.3727/105221615X14181438356292 · DOI
- Lee, 2014, β-Catenin signaling in hepatocellular cancer: implications in inflammation, fibrosis, and proliferation, Cancer Lett., 343, 90, 10.1016/j.canlet.2013.09.020 · DOI
- Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
- Kanehisa, 2000, KEGG: kyoto encyclopedia of genes and genomes, Nucleic Acids Res., 28, 27, 10.1093/nar/28.1.27 · DOI · Paper page
Cited by
Structure of the endosomal Commander complex linked to Ritscher-Schinzel syndrome
Healy, M. D., McNally, K. E., Butkovič, R., Chilton, M., Kato, K., Sacharz, J., McConville, C., Moody, E. R. R., Shaw, S., Planelles-Herrero, V. J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.003 · Cited by 91
Metadata
- Authors
- Zheng, L., You, N., Huang, X., Gu, H., Wu, K., Mi, N., & Li, J.
- Venue
- Molecular Therapy Oncolytics
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 12
- Pages
- 112-123
- ISSN
- 2372-7705
- Cited by
- 33
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Natural Science Foundation of China (81372561, 81672902)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells. https://app.cochat.ai/papers/10.1016/j.omto.2018.12.006
- The paper
- Zheng, L., You, N., Huang, X., Gu, H., Wu, K., Mi, N., & Li, J. (2019). COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells. Molecular Therapy Oncolytics. https://doi.org/10.1016/j.omto.2018.12.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.